Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer.

Shah, MH; Sherman, EJ; Robinson, B; Solomon, BJ; Kang, H; Lorch, JH; Worden, FP; Brose, MS; Leboulleux, S; Godbert, Y; Meurer, M; Morris, JC; Owonikoko, TK; Tan, DSW; Gautschi, O; Patel, JD; Yang, LX; Kherani, J; Cabanillas, ME; Wirth, LJ

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索